Skip to content
Catalyst

PapersPMID:40327637

Effects of additional oral theophylline with inhaled therapy in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis.

PloS one2025The record ↗

  1. Finding, strong evidenceraisesForced expiratory volume in one second (FEV1)

What moved

1 findingHow to read these marks →
  • “Seven studies with 1086 patients reported FEV1 showing a significant improvement of FEV1 in theophylline group with MD 0.08 (95% CI: 0.06 to 0.09, p<0.00001, I2 = 50%).”
    Study
    meta-analysis
    Participants
    1,086
    Effect
    0.08 mean difference, 95% CI 0.06 to 0.09
    Population
    Adults with stable COPD; pooled randomised trials of theophylline added to regular inhaled therapy (inhaled therapy continued in the comparator arms)

Study record

Design
meta-analysis
Species
human
Population
Adults with stable chronic obstructive pulmonary disease
Participants
2,771
Comparator
no treatment
Duration
not reported
Endpoints measured
12